On March 27, 2026, the usually quiet streets near Neogen’s Lansing, Michigan warehouse were anything but silent. Warehouse workers, rallied by Teamsters Local 243, gathered at 10 a.m. near downtown, holding signs and calling for what they described as their first fair contract. Their demands? Better pay, more respect in the workplace, and a stronger voice at the company. For Neogen—a key player in the food and animal safety industry—this labor action arrived at a pivotal moment, drawing sharp attention from both the local community and national investors.
According to reporting from WLNS and WKAR, the rally was not a strike, but a protest intended to intensify the ongoing labor dispute. The union accused Neogen of unfair labor practices, including alleged interference with employees’ rights to organize. The National Labor Relations Board (NLRB) defines such conduct as actions that could undermine workers’ ability to collectively bargain. Teamsters Local 243 described the push as a fight for a first agreement at the Lansing warehouse, highlighting long-standing tensions between management and the workforce.
The roots of this conflict stretch back further than this week’s events. In September 2024, WKAR reported on an NLRB complaint alleging that Neogen managers had threatened workers with the loss of benefits and even suggested moving work out of state if they voted to unionize. Neogen denied these claims, even as city officials approved tax incentives for a $208 million expansion at the time. In February 2025, the company stated that the NLRB had withdrawn the unfair labor practices claim after a mutual agreement, with no admission of wrongdoing. Amy Rocklin, Neogen’s chief legal and compliance officer, said then that the company was committed to a “supportive and equitable workplace where employees feel valued and heard.”
But for the workers outside the warehouse last Friday, the sense of urgency was palpable. Their rally comes as Neogen faces a complex operational and financial picture. In January 2026, the company reported second-quarter fiscal revenue of $224.7 million—a 2.8% decrease from the year before. Still, management raised full-year revenue guidance to between $845 million and $855 million, signaling cautious optimism. Chief Executive Mike Nassif told investors that Neogen was focused on “improving profitability and delivering shareholder value.” Yet, these ambitions are now being tested by both internal labor friction and external market pressures.
Labor risk isn’t the only challenge on Neogen’s plate. The company is in the midst of integrating 3M’s former food safety business, a move management hopes will lift both growth and margins. Automation and production gains at a new Petrifilm production facility are expected to drive improvements in gross margin and EBITDA margin, according to Simply Wall St. The company is also targeting reductions in inefficiencies tied to sample collection and inventory management. However, these operational gains are dependent on smooth integration and relief from ongoing trade and tariff pressures—variables that are far from guaranteed.
For investors, the timing of the labor rally couldn’t be more significant. Neogen’s financial performance has been a rollercoaster. Over the past year, the company posted a total shareholder return of just 0.69%. The five-year picture is even starker, with an 80.52% decline in total shareholder return. Share momentum has been volatile: a 20.50% climb over the last 90 days was quickly erased by a 22.53% drop in the 30 days leading up to March 29, 2026. As of the most recent close, Neogen’s stock traded at $8.70—down from a previous close of $9.15.
Valuation metrics reflect this uncertainty. The most-followed narrative among analysts pegs Neogen’s fair value at $8.17 per share, slightly below the last close of $8.70. That means shares are about 6.5% overvalued at current levels, yet they remain roughly 34.10% below the average analyst price target. On a price-to-sales basis, Neogen trades at 2.1x—cheaper than the US Medical Equipment industry average of 2.7x and below peers at 2.9x, but still above a stated fair ratio of 1.2x. This creates tension: is Neogen a discounted entry point for investors, or is the market already pricing in the risks of future growth and ongoing labor disputes?
“Labor pressures could mean higher wage costs or short-term operational friction,” Simply Wall St noted in a recent analysis. If the company is forced to raise wages or faces operational slowdowns due to labor unrest, the projected gains from automation and efficiency improvements could be offset—potentially derailing the margin-repair narrative that management has been pitching to investors. In other words, the outcome of these labor negotiations could directly impact Neogen’s bottom line and its perceived value in the market.
From a broader perspective, the March 27 rally serves as a near-term stress test for Neogen’s execution capabilities. Will the company be able to address workers’ concerns without sacrificing the operational improvements necessary for its long-term recovery? Or will ongoing friction increase costs and delay the integration of new business units, forcing investors to reassess the company’s fair value and recovery timeline?
Local consequences are concentrated in Lansing, where the warehouse action has the potential to disrupt operations. But if the dispute escalates or spreads, national and sector-level ramifications could follow. For now, the rally remains a protest, not a strike. However, a protracted contract fight could raise labor costs or slow operations at a time when Neogen is still working through integration, transformation, and internal control risks.
For the company’s workforce, the message is clear: they want to be heard, respected, and fairly compensated. For management and investors, the challenge is to balance those demands with the need to restore profitability and shareholder value. As Neogen navigates this narrow window of risk and reward, every move—on the picket line and in the boardroom—will be closely watched.
What happens next is anyone’s guess. But one thing is certain: the events unfolding in Lansing offer a revealing glimpse into the pressures facing American companies at the intersection of labor relations, operational transformation, and financial performance.